Bind Therapeutics is categorized under Noncommercial Biotechnical Research in Cambridge, MA .
| Business Name: | Bind Therapeutics |
| Contact Person: | Scott Minick, Chief Executive Officer |
| Address: | 325 Vassar St, Cambridge, Massachusetts 02139 |
| Phone Number: | (617) 491-3400 |
| Website Address: | bindtherapeutics.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founding Year: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Biotechnical Research |
| SIC Code: | 8733 |
| NAICS Code: | 4461100 |
| Share This Business: | |
| Related Businesses: |
Transkaryotic Therapies Inc - Cambridge, MA 02139 Massachusetts Institute Of Technology - Cambridge, MA 02139 Genewiz - Cambridge, MA 02139 |
The company Bind Therapeutics provides B2B services in the form of Noncommercial Biotechnical Research from its single location in Massachusetts. 1 to 4 employees work for Bind Therapeutics, and the business now earns $5.000.000 to $9.999.999 per annum.
Bind Therapeutics was launched in 2006 and is classified under SIC code and category 8733 , and NAICS number and grouping 4461100 . To contact Bind Therapeutics, please call Scott Minick, Chief Executive Officer with the phone number (617) 491-3400 or visit its single location at 325 Vassar St in Cambridge, Massachusetts 02139.
The location of the single location can also be found using the coordinates 42.35488,-71.1056. Read more details about this business on the webpage bindtherapeutics.com or follow the company’s social media accounts, on Twitter and on Facebook.